Cargando…
The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods
Autores principales: | Uceda, Julia, Carmona, Loreto, Muñoz, Alejandro, Marenco, Jose L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509079/ http://dx.doi.org/10.1186/1479-5876-10-S3-P28 |
Ejemplares similares
-
Reasons for Starting and Stopping Electronic Cigarette Use
por: Pepper, Jessica K., et al.
Publicado: (2014) -
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
por: Carolina Da Silva, Ana, et al.
Publicado: (2014) -
Concerns about subgroup analyses and reason for stopping remdesivir trial
por: Vijayaraghavan, Bharath Kumar Tirupakuzhi
Publicado: (2022) -
A systematic survey of randomised trials that stopped early for reasons of futility
por: Walter, S. D., et al.
Publicado: (2020) -
The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial”
por: Murthy, Srinivas
Publicado: (2022)